Clinical Trials Browser

Breast Neoplasms

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Prostatic Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Breast Neoplasms, Carcinoma, Lobular

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Coitus, Hodgkin Disease, Lymphoma

Breast Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Hereditary Breast and Ovarian Cancer Syndrome

Breast Neoplasms

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Clinical Trials

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Oral Aromatase Inhibitors Modify the Gut Microbiome

REMERGE

DOSABEMA

TRIDENT

NEOEPICURE

AdOTAC

PERCEPTION

PALS

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

EXIST

SPAM

CALCIOBS

LCS Bio Sein

BreastVAX

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

BioCellPhe

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

PDO-Mercurial

HCP

Cardiotoxicity of Cancer Therapy (CCT)

B-GLUCANCER2

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

PRAEGNANT

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer